New Industry Report on India Blood Plasma Products Market Status and Prospects [2023-2030] has been released. The report is 120 pages long and provides an overview of the business with key types and applications along with the industrial chain structure. It includes information about the market, such as development trends, competitive landscape analysis, key regions, and their development status. The report also examines advanced approaches and plans, as well as manufacturing processes and cost structures. It analyzes import/export utilities, market figures, cost, price, revenue, and gross productivity of the market.

Request To Download Sample of This Strategic Report: –https://reportocean.us/sample-request/report_id/IND328

The blood plasma products market has been experiencing steady growth over the past few years. The market increased at a CAGR of 11.26% during the FY 2016 to FY 2020 period and is expected to reach INR 10.43 Billion by FY 2025.

Plasma is a major component of the blood that plays an essential role in regulating bodily functions. It constitutes around 55% of the total volume of blood, and comprises more than 700 proteins and other substances. It is a major component used in the treatment of health problems such as haemophilia and autoimmune disorders. Improved diagnostic facilities and the prevalence of chronic diseases are major factors that have raised the demand for plasma-derived products.

The immunoglobulin segment accounted for the major share of the market in 2020 and is projected to maintain its leading position during the forecast period.

Major players operating in the market include Bharat Serums and Vaccines Ltd. (BSV), Intas Pharmaceuticals Ltd., PlasmaGen BioSciences Private Ltd., Serum Institute of India Private Ltd., and Zydus Takeda Healthcare Private Ltd.

Impact of COVID-19

The pandemic in India increased the need for convalescent measures, therapies, and cures for the ailing public. COVID-19 outbreak has pushed scientists to experiment with plasma therapy on infected people with the virus. This COVID-19 crisis highlighted the need for a massive supply of blood plasma for convalescent measures and treatments. Besides, India is heavily dependent on imported plasma products. These products fulfil 90% of the domestic demand, giving rise to a massive gap between demand and supply.

Market segment insights

In FY 2020, the immunoglobulin segment held the highest share (~46.78%) of the overall market. Immunoglobulin is used to treat various blood disorders such as primary and secondary immune deficiencies, and inflammatory and autoimmune diseases. Based on end users, the hospital segment dominated the market in FY 2020. Clinics and other end users segments are expected to expand at a growth rate of ~17.90% and ~24.77%, respectively, during the FY 2021 – FY 2025 period.

Download Sample of This Strategic Report: –https://reportocean.us/sample-request/report_id/IND328

Key growth drivers of the market

The demand for plasma derivative-based therapies has picked up in the wake of the pandemic, propelling market growth. According to a research study published in Blood Medicine Journal in 2016, FIX replacement therapy that comprises plasma-derived protein was found to be successful in reducing bleeding and disability in case of hemophilia B. According to the annual global survey conducted by the World Federation of hemophilia, around 50% of the world’s hemophilia population lives in India. Hemophilia is treated through factor replacement therapy, using clotting factor VIII for hemophilia A and clotting factor IX for hemophilia B
Immunodeficiency can be caused by various chronic illnesses. Immunoglobulin, a crucial part of plasma protein, is used as first-line therapy to treat various immunologic, neurologic, and hematologic conditions. India has shown a remarkable improvement in patient care with Primary Immune Deficiencies (PIDs), and several centers of excellence in PIDs have emerged. Thus, an increase in the demand for immunoglobulin is fueling the growth of the market

Key deterrents to the growth of the market

Plasma derivative-based therapy is a cost-effective solution to develop human plasma products such as antibodies and proteins in the long run. It is an expensive procedure that involves the complicated process of collecting plasma, which requires a large workforce. The cost of plasmapheresis equipment, complex logistics, and donor compensation are very high. Apart from that, low availability of recovered plasma is another major challenge faced by plasma product manufacturers.

Companies covered

Bharat Serums and Vaccines Ltd. (BSV)
Bioviz Technologies Private Ltd.
Intas Pharmaceuticals Ltd.
PlasmaGen BioSciences Private Ltd.
Plasmatech Solutions Private Ltd.
Reliance Life Sciences Private Ltd.
Serum Institute of India Private Ltd.
Taj Pharma India Ltd.
Virchow Biotech Private Ltd.
Zydus Takeda Healthcare Private Ltd.

Request full Report Description, TOC, Table of Figure, Chart, etc. @ –https://reportocean.us/sample-request/report_id/IND328

Our most recent research report showcases the thriving expansion of the global India Blood Plasma Products Market and offers in-depth insights into the projected market size, share, and revenue until 2030.

The report addresses the following key questions regarding the India Blood Plasma Products market:

What is the expected growth rate of the market in the upcoming years and what factors are driving this growth?
How do consumers perceive and adopt different types of India Blood Plasma Products in the market?
How are regulatory policies and government initiatives impacting the growth of the India Blood Plasma Products market?
What is the market share of the top 5 players in the India Blood Plasma Products market and how is it likely to change in the future?
What are the latest technologies and innovations in the India Blood Plasma Products market and how are they shaping the industry landscape?
How do macroeconomic factors such as inflation, GDP, and exchange rates affect the India Blood Plasma Products market?
What are the challenges related to the supply chain and logistics that India Blood Plasma Products market players face and how are they addressing them?
How is the changing consumer behavior and preferences influencing the dynamics of the India Blood Plasma Products market?
What are the potential risks and uncertainties associated with investing in the India Blood Plasma Products market, and how can they be mitigated?

Reasons to Buy This Report

(A) The research provides valuable insights for top administration, policymakers, professionals, product advancements, sales managers, and stakeholders in the market. It helps them make informed decisions and strategize effectively.

(B) The report offers comprehensive analysis of India Blood Plasma Products market revenues on a global, regional, and country level, projecting trends until 2030. This data allows companies to assess their market share, identify growth opportunities, and explore new markets.

(C) The research includes segmentation of the India Blood Plasma Products market based on types, applications, technologies, and end-uses. This segmentation enables leaders to plan their products and allocate resources based on the expected growth rates of each segment.

(D) Analysis of the India Blood Plasma Products market benefits investors by providing insights into market scope, position, key drivers, challenges, restraints, expansion opportunities, and potential threats. This information helps them make informed investment decisions.

(E) The report offers a detailed analysis of competitors, their key strategies, and market positioning. This knowledge allows businesses to better understand the competition and plan their own strategies accordingly.

(F) The study helps evaluate India Blood Plasma Products business predictions by region, key countries, and top companies, providing valuable information for investment planning and decision-making.

Request Full Report –https://reportocean.us/sample-request/report_id/IND328

About Report Ocean:

We are the best market research reports provider in the industry. Report Ocean believes in providing quality reports to clients to meet the top line and bottom-line goals which will boost your market share in today’s competitive environment. Report Ocean is a ‘one-stop solution’ for individuals, organizations, and industries that are looking for innovative market research reports.

Get in Touch with Us:
Report Ocean:
Email: sales@reportocean.com
Address: 500 N Michigan Ave, Suite 600, Chicago, Illinois 60611 – UNITED STATES
Tel:+1 888 212 3539 (US – TOLL FREE)
Website: https://reportocean.us/